Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs.

MLA

Behrens, Christopher R., et al. “Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs.” Molecular Pharmaceutics, vol. 12, no. 11, Nov. 2015, pp. 3986–98. EBSCOhost, https://doi.org/10.1021/acs.molpharmaceut.5b00432.

APA

Behrens, C. R., Ha, E. H., Chinn, L. L., Bowers, S., Probst, G., Fitch-Bruhns, M., Monteon, J., Valdiosera, A., Bermudez, A., Liao-Chan, S., Wong, T., Melnick, J., Theunissen, J.-W., Flory, M. R., Houser, D., Venstrom, K., Levashova, Z., Sauer, P., Migone, T.-S., … Jackson, D. Y. (2015). Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs. Molecular Pharmaceutics, 12(11), 3986–3998. https://doi.org/10.1021/acs.molpharmaceut.5b00432

Chicago

Behrens, Christopher R, Edward H Ha, Lawrence L Chinn, Simeon Bowers, Gary Probst, Maureen Fitch-Bruhns, Jorge Monteon, et al. 2015. “Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs.” Molecular Pharmaceutics 12 (11): 3986–98. doi:10.1021/acs.molpharmaceut.5b00432.